The Pfizer logo appears on a screen above its trading post on the floor of the New York Stock Exchange last week. The biggest U.S.-based drugmaker, Pfizer, will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland, on paper, to reduce its tax bill.
The Pfizer logo appears on a screen above its trading post on the floor of the New York Stock Exchange last week. The biggest U.S.-based drugmaker, Pfizer, will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland, on paper, to reduce its tax bill. Richard Drew Associated Press
The Pfizer logo appears on a screen above its trading post on the floor of the New York Stock Exchange last week. The biggest U.S.-based drugmaker, Pfizer, will stay put thanks to aggressive new Treasury Department rules that succeeded in blocking Pfizer from acquiring rival Allergan and moving to Ireland, on paper, to reduce its tax bill. Richard Drew Associated Press

RedBlueAmerica: Is it wrong for U.S. companies to move overseas for tax breaks?

April 10, 2016 9:55 PM

More Videos

  • Are 'leafers' really a thing?

    Ever heard of the tourists who flock north by bus, car, plane and train to watch the leaves change each autumn? There's a term for them.